These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21315497)

  • 1. Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica.
    Prado-Prado F; García-Mera X; Abeijón P; Alonso N; Caamaño O; Yáñez M; Gárate T; Mezo M; González-Warleta M; Muiño L; Ubeira FM; González-Díaz H
    Eur J Med Chem; 2011 Apr; 46(4):1074-94. PubMed ID: 21315497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
    González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
    J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae.
    González-Díaz H; Prado-Prado F; García-Mera X; Alonso N; Abeijón P; Caamaño O; Yáñez M; Munteanu CR; Pazos A; Dea-Ayuela MA; Gómez-Muñoz MT; Garijo MM; Sansano J; Ubeira FM
    J Proteome Res; 2011 Apr; 10(4):1698-718. PubMed ID: 21184613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
    Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
    Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-target spectral moments for QSAR and Complex Networks study of antibacterial drugs.
    Prado-Prado FJ; Uriarte E; Borges F; González-Díaz H
    Eur J Med Chem; 2009 Nov; 44(11):4516-21. PubMed ID: 19631422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
    Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MISS-Prot: web server for self/non-self discrimination of protein residue networks in parasites; theory and experiments in Fasciola peptides and Anisakis allergens.
    González-Díaz H; Muíño L; Anadón AM; Romaris F; Prado-Prado FJ; Munteanu CR; Dorado J; Sierra AP; Mezo M; González-Warleta M; Gárate T; Ubeira FM
    Mol Biosyst; 2011 Jun; 7(6):1938-55. PubMed ID: 21468430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.
    Prado-Prado F; García-Mera X; Escobar M; Alonso N; Caamaño O; Yañez M; González-Díaz H
    Curr Top Med Chem; 2012; 12(16):1843-65. PubMed ID: 23030618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.
    Santana L; Uriarte E; González-Díaz H; Zagotto G; Soto-Otero R; Méndez-Alvarez E
    J Med Chem; 2006 Feb; 49(3):1149-56. PubMed ID: 16451079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Markov-Shannon Entropy models to assess connectivity quality in complex networks: from molecular to cellular pathway, Parasite-Host, Neural, Industry, and Legal-Social networks.
    Riera-Fernández P; Munteanu CR; Escobar M; Prado-Prado F; Martín-Romalde R; Pereira D; Villalba K; Duardo-Sánchez A; González-Díaz H
    J Theor Biol; 2012 Jan; 293():174-88. PubMed ID: 22037044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors.
    Viña D; Uriarte E; Orallo F; González-Díaz H
    Mol Pharm; 2009; 6(3):825-35. PubMed ID: 19281186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Santana L; González-Díaz H; Quezada E; Uriarte E; Yáñez M; Viña D; Orallo F
    J Med Chem; 2008 Nov; 51(21):6740-51. PubMed ID: 18834112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unified QSAR & network-based computational chemistry approach to antimicrobials. II. Multiple distance and triadic census analysis of antiparasitic drugs complex networks.
    Prado-Prado FJ; Ubeira FM; Borges F; González-Díaz H
    J Comput Chem; 2010 Jan; 31(1):164-73. PubMed ID: 19421992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-target spectral moment: QSAR for antiviral drugs vs. different viral species.
    Prado-Prado FJ; Borges F; Uriarte E; Peréz-Montoto LG; González-Díaz H
    Anal Chim Acta; 2009 Oct; 651(2):159-64. PubMed ID: 19782806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-target spectral moment: QSAR for antifungal drugs vs. different fungi species.
    Prado-Prado FJ; Borges F; Perez-Montoto LG; González-Díaz H
    Eur J Med Chem; 2009 Oct; 44(10):4051-6. PubMed ID: 19467743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-MEDNEs: an alternative "in silico" technique for chemical research in toxicology. 2. quantitative proteome-toxicity relationships (QPTR) based on mass spectrum spiral entropy.
    Cruz-Monteagudo M; González-Díaz H; Borges F; Dominguez ER; Cordeiro MN
    Chem Res Toxicol; 2008 Mar; 21(3):619-32. PubMed ID: 18257557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases.
    Luan F; Cordeiro MN; Alonso N; García-Mera X; Caamaño O; Romero-Duran FJ; Yañez M; González-Díaz H
    Bioorg Med Chem; 2013 Apr; 21(7):1870-9. PubMed ID: 23415089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.